Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,23017,667,1.83 [1.43-2.34],1.7207358735004397e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,22811,659,1.33 [1.18-1.51],7.332455996138792e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,19801,575,1.58 [1.26-1.97],7.56098996294796e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,23336,674,1.55 [1.26-1.89],2.634578011466522e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22811,659,1.39 [1.22-1.59],8.670414717074823e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,23480,678,1.40 [1.16-1.68],0.0004223040653927
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19658,569,1.68 [1.43-1.97],1.814289445204034e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22811,659,1.73 [1.37-2.17],2.9918346639842065e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,23129,678,1.36 [1.16-1.61],0.0002352199293703
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,20218,586,1.79 [1.42-2.27],1.229151708864363e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,19801,575,3.85 [3.17-4.68],1.342063721661144e-41
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,23336,679,1.54 [1.21-1.96],0.0004919944269272
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,23394,677,1.46 [1.17-1.83],0.0007136310932635
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,23227,673,1.57 [1.21-2.02],0.0005792325936715
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,23432,678,1.99 [1.53-2.59],3.231594570407991e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AFM,Afamin,20253,588,2.74 [1.79-4.18],3.1820959618058583e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,23183,678,1.44 [1.22-1.70],1.652592995669481e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,23336,679,2.11 [1.75-2.54],2.346182286158154e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,19801,575,1.77 [1.34-2.35],5.479875956675177e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,23502,678,2.78 [1.97-3.91],4.835189303444266e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,19801,575,2.26 [1.89-2.69],8.634949986236992e-20
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,22913,663,1.88 [1.48-2.37],1.749499730002127e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,23268,678,1.64 [1.38-1.94],1.1402192570506134e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,23297,679,1.72 [1.48-2.00],2.614499205273659e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,23432,678,1.72 [1.44-2.05],1.458058996702104e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,23251,676,1.63 [1.30-2.05],2.8219982163148142e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,23292,676,1.77 [1.41-2.22],8.031818235546055e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,20065,581,2.18 [1.73-2.76],6.420092065763494e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,20229,589,0.48 [0.36-0.63],1.963755526728829e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,23068,663,2.00 [1.71-2.33],1.5059474910410318e-18
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,23068,663,1.56 [1.23-1.96],0.0001907595283892
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,20221,585,1.76 [1.38-2.25],4.707107328743694e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19713,574,1.48 [1.19-1.86],0.0005802834840763
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,22698,655,1.56 [1.26-1.94],6.311148829011407e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,23236,674,2.30 [1.75-3.01],1.7143876395825939e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20221,585,1.55 [1.23-1.95],0.0002166117899427
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,23502,678,1.42 [1.17-1.74],0.0005499976823328
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19801,575,2.15 [1.61-2.87],2.495927888748373e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,19015,556,0.84 [0.78-0.91],1.1308812101730189e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,20184,582,1.44 [1.30-1.60],2.3660948880802442e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,22655,661,1.31 [1.12-1.53],0.0006280905983349
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BSG,Basigin,23439,677,2.12 [1.50-3.01],2.498359493908994e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23292,676,1.41 [1.21-1.65],8.320680105995631e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",C2,Complement C2,23254,675,1.99 [1.42-2.78],5.8644408222159767e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,23302,679,0.74 [0.62-0.87],0.0003060062537296
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19764,574,1.86 [1.43-2.42],3.432739645514714e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,23432,678,0.58 [0.48-0.71],1.0574521697451372e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,23432,678,1.33 [1.15-1.53],9.118447445282524e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19713,574,1.44 [1.28-1.62],3.1726651345480086e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,23502,678,1.54 [1.34-1.78],3.33542936902209e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,23032,662,1.51 [1.33-1.70],5.6443200103110435e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,23006,675,1.30 [1.14-1.47],6.33872430345615e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,23190,675,1.17 [1.07-1.28],0.0008531646441511
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,23190,675,1.27 [1.15-1.40],2.240840235816143e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,23087,676,1.24 [1.13-1.36],7.0784843504245256e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,23469,678,1.89 [1.57-2.26],1.091870471037163e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,23236,674,1.48 [1.20-1.83],0.0002305831733326
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,22720,666,1.36 [1.15-1.60],0.0002909925881104
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,23292,676,1.59 [1.36-1.85],4.069097930168527e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,23190,675,1.71 [1.31-2.23],9.397710296728376e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,23480,678,1.37 [1.16-1.62],0.0001997248362474
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,20218,586,1.45 [1.19-1.77],0.0002074054042998
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,23302,679,0.61 [0.51-0.73],5.1375488674990496e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,23227,679,1.69 [1.39-2.05],1.449297370640384e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,19658,569,1.36 [1.14-1.63],0.000740106060789
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,23397,676,0.66 [0.54-0.82],0.0001534398663972
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,20130,582,0.67 [0.57-0.80],1.1659140844256784e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,23439,677,0.74 [0.65-0.84],2.862638172336913e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19801,575,1.63 [1.36-1.97],2.3180280294643602e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,20221,585,1.78 [1.43-2.23],3.7034712659576987e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,23190,675,1.56 [1.28-1.90],1.2011811070329689e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,23190,675,0.59 [0.47-0.73],2.882343584512936e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,22322,652,1.87 [1.50-2.31],1.3200736312185954e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,23236,674,1.72 [1.29-2.30],0.0002083908653092
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,23068,663,1.54 [1.35-1.76],7.762263072944839e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,23502,678,2.04 [1.65-2.52],5.383918785004319e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,23227,673,1.55 [1.29-1.88],4.950724861795936e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,23269,679,1.84 [1.41-2.40],5.495652566650887e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,23263,678,2.06 [1.49-2.84],1.0743781871351422e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20121,584,1.33 [1.20-1.48],9.952745538514969e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19801,575,6.75 [5.32-8.58],5.178923490653659e-55
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",20182,585,1.41 [1.17-1.70],0.0003215063209644
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,19664,573,1.38 [1.19-1.61],2.7618684422603e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,23371,677,1.72 [1.36-2.17],6.7528904980646695e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,20218,586,0.76 [0.66-0.87],3.996575981978908e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,23236,674,1.77 [1.43-2.18],1.08328180953277e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,23190,675,0.76 [0.65-0.88],0.000238099594956
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,23323,675,1.66 [1.23-2.23],0.0008178309015171
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,23502,678,2.12 [1.64-2.75],1.1648985028906252e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,20121,584,1.54 [1.32-1.80],3.8609673935413686e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,23227,673,1.62 [1.37-1.92],1.1113644503555591e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19801,575,2.10 [1.76-2.50],1.180470170899653e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,23502,678,1.67 [1.38-2.01],7.499835300875274e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,23190,675,1.59 [1.40-1.81],9.425099780739661e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,23227,679,2.33 [1.80-3.01],1.0751011634392999e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,20176,586,1.51 [1.20-1.91],0.0005459149645274
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,20221,585,1.73 [1.31-2.29],0.0001214978110875
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,22925,669,1.83 [1.53-2.18],2.039821580447656e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,19801,575,1.82 [1.47-2.25],2.759129980002241e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,23336,679,2.17 [1.57-3.00],3.065472454661329e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,20044,584,0.50 [0.38-0.67],3.1118689194580613e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,23336,679,0.46 [0.35-0.59],4.135921657275585e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,23336,679,2.28 [1.80-2.88],7.140921453795865e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,19609,570,1.59 [1.30-1.94],5.275114081866727e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,22791,663,1.47 [1.29-1.68],9.275000450632957e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,20218,586,2.29 [1.80-2.91],1.0791885086857992e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,23258,675,1.53 [1.21-1.94],0.0004636603579622
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,19927,581,1.77 [1.30-2.41],0.0002794819348384
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,20218,586,2.20 [1.70-2.86],2.814361616365922e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,23247,675,0.76 [0.67-0.87],6.410365312675435e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,23227,673,1.69 [1.28-2.23],0.0002173524113065
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,23480,678,2.24 [1.82-2.77],4.93369255359846e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,23212,675,2.34 [1.89-2.90],5.22996635671402e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,23068,663,1.73 [1.42-2.10],3.3547370850657767e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,23463,678,1.83 [1.38-2.44],3.290453797722033e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,23046,667,1.23 [1.13-1.34],1.3411697430500565e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23302,679,0.67 [0.56-0.82],7.74700728842881e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,23227,673,1.91 [1.54-2.36],4.178715102705866e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,23433,680,1.84 [1.38-2.45],2.9510607572276307e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,19595,564,0.81 [0.71-0.92],0.0009723766944953
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,19801,575,2.22 [1.69-2.92],9.752398140535109e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,23502,678,2.26 [1.80-2.84],1.5111422004094942e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,23502,678,1.31 [1.15-1.49],4.814055890469074e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,19713,574,1.38 [1.20-1.59],9.8411358568322e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22773,665,2.19 [1.74-2.77],4.3242513839907485e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,23502,678,2.82 [2.12-3.74],7.328431542019773e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,23355,674,1.20 [1.08-1.33],0.0008946039583353
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,23068,663,1.32 [1.13-1.55],0.0006253414910728
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,23129,678,2.13 [1.63-2.78],2.1939179158455e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,23432,678,2.15 [1.81-2.55],2.432627752302881e-18
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22811,659,1.48 [1.22-1.78],4.5747023285905255e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,19713,574,1.59 [1.22-2.09],0.0007685637186699
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,20121,584,1.54 [1.22-1.95],0.0003184835321682
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,23502,678,0.36 [0.23-0.54],1.097054425162787e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ELN,Elastin,20221,585,1.90 [1.53-2.36],6.4971797620230475e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22791,663,1.37 [1.20-1.57],4.731901976248327e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,23299,676,0.70 [0.57-0.85],0.0003727720477415
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,22411,661,1.68 [1.36-2.07],1.3125855006511425e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,19801,575,1.82 [1.37-2.42],4.1218299426035565e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,23502,678,1.83 [1.40-2.39],8.050514516010476e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,23020,663,1.84 [1.48-2.30],6.313004257515315e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,23190,675,1.25 [1.15-1.35],1.81912349992428e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,23302,679,3.10 [2.34-4.12],3.909200802392567e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,23164,676,2.30 [1.62-3.26],2.706393961070386e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,20109,578,1.45 [1.21-1.74],6.148540428394313e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,23227,679,1.43 [1.17-1.74],0.0005472428126101
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,23292,673,1.74 [1.37-2.22],5.726320942124857e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,23254,675,1.99 [1.35-2.91],0.0004417926994289
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",23227,679,1.16 [1.08-1.25],4.30985810777843e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",23502,678,1.55 [1.36-1.77],3.7362882357226016e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,20221,585,1.59 [1.21-2.09],0.0009517929145629
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,20218,586,2.17 [1.70-2.76],3.1189195642024075e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,23236,674,1.74 [1.51-2.00],2.6304606510718395e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,23370,675,0.56 [0.48-0.66],1.5812565182928253e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,23254,675,1.91 [1.53-2.37],6.307816009560168e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,23302,679,2.34 [1.72-3.17],4.8322898682713415e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,23480,678,4.00 [3.27-4.89],1.44258219462151e-41
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,20182,585,1.49 [1.25-1.77],9.90167854531544e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,23433,680,1.73 [1.37-2.17],2.963156406910968e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,19713,574,1.28 [1.14-1.45],4.310124351112496e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,23190,675,1.62 [1.32-2.00],6.429037230054686e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23433,680,2.05 [1.77-2.37],1.8700986953838723e-21
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,23354,677,2.87 [2.20-3.74],6.1872842354340856e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,23502,678,1.56 [1.38-1.77],3.305093949315587e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,23227,673,1.83 [1.52-2.21],3.4574356154072887e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,23392,677,2.00 [1.58-2.53],8.033067123771443e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,22821,667,1.57 [1.30-1.89],3.0255464580587475e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,23068,663,1.93 [1.45-2.57],6.234315644108396e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,19801,575,1.68 [1.26-2.25],0.0003784890331145
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,19758,575,1.53 [1.24-1.88],7.10628318988539e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,23433,680,2.05 [1.55-2.73],6.901580891668807e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,23432,678,1.73 [1.37-2.19],4.6210792179173096e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,22600,659,2.13 [1.66-2.73],2.520451372809028e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,22811,659,1.22 [1.10-1.36],0.0001836063715289
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",20107,586,1.85 [1.29-2.66],0.0008871238569873
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,23336,674,1.56 [1.40-1.74],3.3387466922160096e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,23397,676,1.27 [1.14-1.42],1.806354919528716e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,23236,674,1.60 [1.32-1.93],1.7256880646012085e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,19801,575,2.41 [1.78-3.26],1.429474061573179e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,22972,667,1.51 [1.31-1.74],9.776275436627248e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23432,678,1.68 [1.40-2.02],1.853562804821376e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,23190,675,0.73 [0.61-0.87],0.0003422840352057
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,20182,585,1.31 [1.16-1.48],1.824310939430808e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23031,672,1.75 [1.37-2.26],1.147175715869837e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,23112,674,1.81 [1.44-2.27],4.481198897356833e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19621,565,1.91 [1.58-2.30],9.497726452551194e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,23336,679,2.16 [1.55-3.01],4.93126827056684e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,23463,678,1.12 [1.05-1.18],0.0002476634179931
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,23462,677,0.77 [0.69-0.86],1.7186007259444878e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,23292,676,1.92 [1.48-2.49],1.1141807956787762e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22932,665,1.56 [1.35-1.82],5.688663526722644e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,23227,673,1.70 [1.40-2.06],5.02136965980594e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,19658,569,1.16 [1.06-1.26],0.0007300018598226
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,23129,678,1.65 [1.39-1.96],1.0937234939976593e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,23336,679,1.77 [1.42-2.20],4.228526209163461e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,22936,667,2.34 [1.68-3.25],4.999801142259156e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,23190,675,1.62 [1.33-1.98],1.640825467349776e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,22889,667,1.27 [1.12-1.45],0.0003236250701196
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,23148,675,1.40 [1.23-1.60],5.855189747449658e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,23292,676,1.45 [1.17-1.80],0.0007705711958161
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,22647,657,1.20 [1.09-1.32],0.0002700961842088
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,23236,674,0.61 [0.52-0.72],6.150181266814608e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,23190,676,1.31 [1.17-1.46],1.1232996584153711e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,22791,663,1.26 [1.10-1.43],0.0007028964261574
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,23049,665,1.45 [1.23-1.72],1.0063452320158826e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,23190,675,1.32 [1.13-1.54],0.0003944890935097
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,23190,675,0.74 [0.65-0.84],5.303628479517899e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,23227,673,2.18 [1.49-3.18],5.520690471020221e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,20109,578,1.45 [1.25-1.68],6.955118219354862e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,23236,674,1.44 [1.21-1.70],2.4241481783037785e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,23190,675,1.76 [1.48-2.09],1.3827487564759369e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,23236,674,1.86 [1.42-2.44],7.581576872797142e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,23181,673,1.68 [1.24-2.27],0.000715685731485
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,20218,586,1.73 [1.41-2.13],1.861188275256765e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,23433,680,2.03 [1.58-2.60],2.6646899959472453e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,20182,585,1.50 [1.19-1.90],0.0007119548706371
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,23227,673,0.71 [0.59-0.85],0.0002363311287594
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,23432,678,1.54 [1.40-1.70],6.413118146315975e-18
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23227,679,1.37 [1.16-1.62],0.000270213737814
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,19713,574,2.06 [1.56-2.72],3.248637453493133e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,23439,677,1.31 [1.15-1.48],3.311120294309232e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,23020,663,1.63 [1.35-1.98],6.172773087788559e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,22506,655,0.71 [0.59-0.86],0.0005854492576191
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,20218,586,1.32 [1.13-1.55],0.0005201955240008
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,23289,674,1.25 [1.10-1.42],0.0008397195993383
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,20253,588,1.59 [1.27-1.99],4.4172865797258855e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,23227,679,1.27 [1.12-1.44],0.0001752226549761
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,23229,679,1.88 [1.54-2.31],8.22193156412541e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,23190,675,1.90 [1.46-2.48],1.5847481197118209e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22791,663,1.35 [1.16-1.58],0.0001536372583237
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,20078,584,1.25 [1.12-1.40],8.933625141721791e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,20182,585,2.38 [1.88-3.01],3.8876660483656293e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,23129,678,2.43 [1.91-3.09],4.341374063768841e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,23227,673,1.64 [1.35-1.98],3.323502783511584e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23433,680,1.22 [1.10-1.35],0.000214311802145
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,19835,576,1.21 [1.12-1.29],2.0480126526376417e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,23432,678,1.26 [1.13-1.41],4.697452331868303e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,23502,678,2.38 [1.94-2.92],5.782999361734204e-17
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,23122,676,1.91 [1.51-2.41],6.755326440763908e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,23110,674,1.60 [1.32-1.93],1.2403105400373145e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20253,588,3.06 [2.06-4.54],2.6763199683289723e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,19510,565,2.25 [1.92-2.62],1.9060967114798412e-24
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22983,662,1.25 [1.11-1.41],0.0001995588045044
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,20221,585,2.40 [1.93-2.98],2.05378891281723e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,20109,578,1.36 [1.18-1.57],2.040372302074356e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,20221,585,1.33 [1.16-1.53],3.627966101861323e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,23269,679,1.47 [1.17-1.86],0.0009879978977249
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,23292,676,1.64 [1.35-1.99],6.975347184781272e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",20190,584,1.34 [1.15-1.55],0.0001177039736375
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,23068,663,1.26 [1.14-1.40],8.688577212145164e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,23227,679,1.46 [1.21-1.74],4.648410675724495e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,23434,678,3.91 [2.86-5.36],1.76999215525852e-17
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,20221,585,1.99 [1.52-2.60],5.220874780418157e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,23227,679,0.55 [0.43-0.69],4.296895082892306e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,23285,674,2.98 [2.13-4.19],2.613179723699625e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,19801,575,1.79 [1.39-2.31],6.283445699408767e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,23502,678,0.64 [0.54-0.76],1.0289618022379673e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,23244,670,1.28 [1.12-1.45],0.0002029552802073
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,22655,661,1.72 [1.40-2.13],4.250081927977618e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,23236,674,0.67 [0.57-0.77],1.5779067265167754e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,20229,589,1.96 [1.50-2.56],6.797512445875072e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,23433,680,1.62 [1.40-1.89],4.21983167293419e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,23236,674,1.30 [1.12-1.52],0.000620733833673
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22960,660,1.32 [1.18-1.48],1.5804149885093005e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19801,575,2.09 [1.43-3.07],0.0001553134801506
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,23433,680,1.44 [1.19-1.73],0.0001291917676211
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20121,584,1.72 [1.37-2.17],3.198416689744029e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,23432,678,1.66 [1.31-2.11],3.4295709580463583e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,23192,672,1.70 [1.35-2.14],6.009768122984917e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,23302,679,1.49 [1.21-1.84],0.0001665574170306
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,22574,659,1.58 [1.35-1.84],6.3240126642427324e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,23480,678,2.12 [1.67-2.70],1.0394249435820488e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,23236,674,1.98 [1.50-2.61],1.1984949650063969e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,23502,678,2.25 [1.46-3.48],0.0002590156874581
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,20218,586,1.90 [1.33-2.72],0.0004599163104742
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,23227,673,1.43 [1.16-1.76],0.0009537156711599
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,20221,585,1.76 [1.50-2.08],1.7276209683832975e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,22811,659,1.15 [1.08-1.21],1.4726075150239091e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,23190,675,1.50 [1.29-1.75],1.76119421539987e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,23236,674,1.40 [1.18-1.66],0.0001215545935854
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,23227,673,1.53 [1.20-1.93],0.0005085466823261
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,23336,677,2.05 [1.62-2.60],3.462350926817156e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,23236,674,2.39 [1.93-2.96],1.276863844961032e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,20182,585,1.72 [1.42-2.08],2.95253520291292e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,23227,673,1.18 [1.11-1.27],5.166608191734595e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,22994,660,0.83 [0.74-0.92],0.0003465520144866
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,20190,584,1.35 [1.14-1.61],0.0005650680753322
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,23236,674,1.64 [1.39-1.93],2.3118229210269627e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,23336,679,1.75 [1.48-2.06],3.7624923100692496e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,23068,663,0.86 [0.80-0.92],5.788378953651259e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,20014,580,1.57 [1.22-2.03],0.0005441328478362
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,20182,585,1.88 [1.56-2.26],3.615229148868048e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,23371,676,1.66 [1.28-2.16],0.0001434298527771
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,20190,584,1.80 [1.34-2.41],9.622461522369464e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,23227,673,1.84 [1.53-2.23],2.2012894728873847e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,20121,584,1.43 [1.19-1.72],0.0001026584062672
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,22698,655,0.64 [0.50-0.82],0.0004094024623494
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,23227,673,1.95 [1.55-2.45],1.3186561852327633e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,19801,575,1.62 [1.25-2.10],0.0002497000504904
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19658,569,1.39 [1.19-1.64],5.65791434047569e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,20229,589,1.26 [1.13-1.42],5.150263766143671e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,23480,678,2.12 [1.73-2.59],6.012048559260055e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,23394,677,0.70 [0.59-0.84],5.905826589777514e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19987,580,2.20 [1.69-2.87],4.900040113225255e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,20121,584,1.31 [1.14-1.52],0.0002315077533993
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,20229,589,1.88 [1.37-2.59],0.0001113146730074
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,22935,660,1.45 [1.20-1.75],0.0001116294244665
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,22655,661,1.41 [1.18-1.68],0.0001283363167748
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,23398,675,1.91 [1.44-2.55],8.647724346278788e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,23336,679,0.68 [0.57-0.82],7.390877660527855e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,20218,586,1.56 [1.27-1.91],2.2004548238580613e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,20218,586,1.58 [1.30-1.92],4.154118253963432e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,23363,671,1.72 [1.41-2.10],1.19508406291657e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,20218,586,0.73 [0.62-0.86],0.0001154974601755
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,23433,680,0.81 [0.73-0.89],1.0057365138641767e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,20182,585,1.50 [1.31-1.73],9.729580670533688e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,19713,574,1.44 [1.17-1.78],0.000629086903928
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,19658,569,1.46 [1.22-1.74],3.920061961576419e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,23151,673,2.01 [1.52-2.66],9.968625978241477e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20221,585,1.99 [1.57-2.53],1.6046376768667776e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,22557,653,1.35 [1.21-1.52],3.33000245100986e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,23190,675,1.44 [1.24-1.69],3.6371737048931615e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,23433,680,1.52 [1.27-1.82],3.4057584170686303e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,20190,584,1.77 [1.49-2.09],3.2837920045102806e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19713,574,2.28 [1.53-3.39],4.600299902667504e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,23129,678,1.72 [1.46-2.03],8.694012113629959e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,19765,575,0.85 [0.78-0.94],0.000874450693921
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,19713,574,1.62 [1.27-2.07],9.477805370178822e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,23269,679,2.50 [1.93-3.25],4.391251816087785e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,23433,680,3.05 [2.30-4.05],1.0301388054863321e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23227,673,1.78 [1.43-2.21],2.332893363797595e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,23432,678,1.49 [1.24-1.79],2.0447705825779343e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,23433,680,1.58 [1.26-1.99],9.943582263136378e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22634,651,1.90 [1.53-2.35],3.873086578302889e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,23433,680,1.84 [1.46-2.32],3.130450327177135e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,20221,585,2.61 [2.02-3.36],1.3137067410879214e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,23227,673,1.75 [1.51-2.03],1.897119510762935e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,23227,673,0.72 [0.62-0.83],1.1726766940178595e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,23190,675,0.62 [0.49-0.78],3.924532170395383e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,23433,680,0.68 [0.54-0.85],0.00074130840574
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,20190,584,0.81 [0.72-0.91],0.0002850680292429
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,20140,584,1.82 [1.46-2.25],5.754313965037871e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,19855,577,6.56 [2.56-16.82],9.100399932889598e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,23502,678,1.64 [1.38-1.95],2.1923256247433143e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,22569,658,1.16 [1.10-1.23],3.1519011659257674e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,20168,583,3.23 [1.99-5.24],2.082856780770783e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19941,580,1.62 [1.32-1.99],3.4844911127885536e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,20253,588,8.69 [5.99-12.60],4.3260749047706925e-30
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,20253,588,2.19 [1.47-3.27],0.0001220414942512
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,22997,677,1.18 [1.08-1.30],0.0004823688823026
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,19943,580,1.70 [1.26-2.28],0.0004300495715691
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,23302,679,1.59 [1.24-2.04],0.0002392637198775
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,23000,661,1.43 [1.23-1.66],3.438778231866149e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,23227,673,1.22 [1.10-1.35],0.0001798844474971
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,23190,675,0.77 [0.67-0.88],0.0002348313814032
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,23336,679,1.58 [1.35-1.84],6.9173442205080306e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,23190,675,1.44 [1.17-1.77],0.0006795705147418
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,22791,663,0.68 [0.60-0.78],8.678806791620258e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,23020,663,0.71 [0.65-0.79],1.5339720689917097e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,22811,659,1.45 [1.20-1.76],0.0001380430591326
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,23129,678,0.57 [0.42-0.79],0.0006868980161055
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,23317,677,1.37 [1.19-1.57],1.263842933345864e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,23068,663,1.25 [1.12-1.39],4.01275578408204e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",23236,674,1.39 [1.18-1.65],0.0001230435647973
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,19801,575,0.62 [0.50-0.77],1.643981266528237e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,23172,674,1.92 [1.50-2.46],2.254105328665919e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,23269,679,2.43 [2.00-2.94],1.6801749564655984e-19
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,23462,677,1.97 [1.71-2.27],1.2603452108349136e-20
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,20221,585,1.52 [1.20-1.94],0.0006445515256188
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,23192,672,0.87 [0.81-0.93],8.97355967696707e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23292,676,1.40 [1.18-1.65],7.10856478641338e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,23433,680,1.50 [1.28-1.75],3.422290404178521e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,23203,674,0.44 [0.35-0.55],2.038956152772141e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,23190,675,1.31 [1.18-1.46],5.819709055115956e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,19679,569,1.75 [1.38-2.23],4.698140162737339e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,23029,663,1.36 [1.27-1.46],6.096068099556196e-17
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,23302,679,1.94 [1.41-2.65],3.730054933630381e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,23297,679,1.47 [1.32-1.64],4.87542602593711e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,23183,671,1.37 [1.23-1.53],1.2591024653868721e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,23302,679,1.53 [1.25-1.87],4.41730468926528e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,23227,673,1.62 [1.27-2.07],9.765551713666612e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,23236,674,1.55 [1.31-1.84],5.593812930645571e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,23214,675,1.34 [1.15-1.56],0.0002017398675793
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,23433,680,1.59 [1.25-2.02],0.0001462954633195
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22959,662,1.64 [1.36-1.98],2.792722787492029e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,23292,676,1.46 [1.27-1.68],8.98231525922717e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,23068,663,1.51 [1.23-1.84],5.306286064483419e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,23068,663,1.27 [1.14-1.42],2.555531462247544e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23480,678,1.42 [1.20-1.69],6.364653659448341e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,23227,679,1.60 [1.27-2.01],5.408135951461089e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23269,679,0.38 [0.30-0.48],1.3733809287262106e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19801,575,0.71 [0.58-0.87],0.0007898104195813
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23439,677,1.44 [1.21-1.72],3.276187003413924e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,23068,663,1.23 [1.09-1.39],0.000609937275981
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23463,678,2.44 [1.97-3.02],2.980981259526127e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,20218,586,1.26 [1.13-1.41],3.4736571942931005e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,23227,679,1.30 [1.14-1.49],6.823489692490163e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,23068,663,1.38 [1.15-1.65],0.0005828508896481
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,20109,578,1.33 [1.18-1.51],6.062367926617108e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,23203,674,1.40 [1.19-1.66],8.224612759105298e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22698,655,1.52 [1.25-1.86],3.420631956495386e-05
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,23392,677,1.35 [1.15-1.59],0.0002754378128153
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,22984,662,1.64 [1.37-1.95],5.6658918906136615e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,23502,678,1.19 [1.08-1.31],0.0002784194749927
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",23269,679,1.41 [1.16-1.71],0.000614592258048
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,23432,678,1.56 [1.28-1.89],9.967666668616692e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,20182,585,2.23 [1.72-2.91],2.3487298625191358e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,20121,584,1.26 [1.13-1.41],2.580532523406953e-05
